Not Yet Recruiting
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
NCT07160790
- Conditions
- Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +5 more
- Locations
-
Not specified